What is the global market size of Malabsorption Syndrome Market?

Global Malabsorption Syndrome Market size was valued at USD 2.29 billion in 2022 and is poised to grow from USD 2.43 billion in 2023 to USD 3.94 billion by 2031, growing at a CAGR of 6.2% during the forecast period (2024-2031).

Malabsorption Syndrome Market Size, Share, Growth Analysis, By Causative Diseases(Celiac Disease, Intestinal Disorders, Whipple’s Disease, Short Bowel Syndrome), By Diagnostic Tools(Imaging (MRI, CT scans), Blood Tests (Serum nutrient levels, Genetic testing)), By Treatment Modalities(Medications (Enzyme replacement, Anti-inflammatory drugs), Nutritional Supplements (Vitamins, Minerals)), By End-User(Hospital Pharmacy, Nutrition Clinics, Academic & Research Institutes, others), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35D2205 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 97 | Figures: 75

Malabsorption Syndrome Market News

March 2023: Indivior PLC (LSE: INDV) has efficiently concluded the acquisition of Opiant Pharmaceuticals, Inc. This strategic pass enhances Indivior’s addiction remedy and scientific portfolio through incorporating Opiant’s late-level belongings.

November 2023: Infants and young youngsters recognized with a rare and terminal genetic disease now have to get admission to a lifestyles-saving remedy through the National Health Service (NHS). Sebelipase alfa (Kanuma®), an enzyme replacement remedy, marks the inaugural NHS-approved treatment for Wolman disorder.

Malabsorption Syndrome Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Malabsorption Syndrome Market size was valued at USD 2.43 Billion in 2023 and is poised to grow from USD 2.58 Billion in 2024 to USD 4.18 Billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).

The competitive environment of the Malabsorption Syndrome marketplace is dynamic and is characterised via the presence of several key gamers and a mixture of hooked up pharmaceutical organizations, diagnostic gadget producers, and emerging biotechnology firms. Companies working on this marketplace are actively engaged in studies and improvement to introduce revolutionary diagnostic equipment and healing solutions. 'AbbVie', 'Actelion Pharmaceuticals', 'Alnylam Pharmaceuticals', 'Allergan', 'Amgen', 'AstraZeneca', 'Bayer Healthcare', 'BioMarin Pharmaceutical', 'Boehringer Ingelheim', 'Chiesi Pharmaceuticals', 'Eli Lilly and Company', 'Gilead Sciences', 'Johnson & Johnson', 'Medtronic', 'Nestle Health Science', 'Novo Nordisk', 'Pfizer', 'Roche', 'Takeda Pharmaceutical Company'

The growing prevalence of malabsorption disorders, pushed by means of factors such as changing lifestyles, dietary styles, and a growing getting older populace, has considerably boosted the demand for diagnostic and treatment answers. Advances in diagnostic technology and a growing consciousness among healthcare providers and sufferers have facilitated early detection and intervention, definitely impacting marketplace boom.

Rising Focus on Personalized Medicine: The growing attention on personalized remedy, with a developing emphasis on tailoring diagnostic and treatment strategies to character patient profiles. This fashion aligns with advancements in genetic checking out and biomarker identification, allowing greater precise and centered interventions. Additionally, there's a sizable shift towards the development of novel therapeutic modalities, along with biologics and gene cures, reflecting an ongoing dedication to addressing the diverse reasons of malabsorption issues.

North America, specifically America, has historically been a dominant player inside the healthcare market. Factors inclusive of a properly-installed healthcare infrastructure, high healthcare expenditure, and advanced diagnostic and treatment technology make contributions to the dominance of North America in the Malabsorption Syndrome market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Malabsorption Syndrome Market News

Malabsorption Syndrome Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Malabsorption Syndrome Market?

Who are the key vendors in the Malabsorption Syndrome Market?

What is the key driver of Malabsorption Syndrome Market?

What is the key market trend for Malabsorption Syndrome Market?

Which region accounted for the largest share in Malabsorption Syndrome Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300